Showing results (1901-1910 of 3,086) with videos related to

Sort By:
Pageof 309
Drug Safety|November 6, 1998
A risk-benefit assessment of epoetin in the management of anaemia associated with cancerY Beguin
Drug Safety|November 6, 1998
A risk-benefit assessment of pharmacotherapy for anxiety disorders in children and adolescentsS M Hawkridge, D J Stein
Drug Safety|November 6, 1998
Treating gastro-oesophageal reflux disease during pregnancy and lactation: what are the safest therapy options?C N Broussard, J E Richter
Drug Safety|November 24, 1998
Does thalidomide cause second generation birth defects?D Smithells
Drug Safety|November 24, 1998
Treatment of inflammatory rheumatic disorders in pregnancy: what are the safest treatment options?M Ostensen, R Ramsey-Goldman
Drug Safety|March 10, 2006
Safety and tolerability of the antibacterial rifaximin in the treatment of travellers' diarrhoeaCharles D Ericsson
Drug Safety|March 10, 2006
Camptothecin and podophyllotoxin derivatives: inhibitors of topoisomerase I and II - mechanisms of action, pharmacokinetics and toxicity profileJörg T Hartmann, Hans-Peter Lipp
Drug Safety|March 10, 2006
Continuation of amiodarone therapy despite type II amiodarone-induced thyrotoxicosisLaurent Uzan, Laurence Guignat, Christophe Meune, et al.
Drug Safety|July 1, 1991
Prevention and management of drug-induced peripheral neuropathyL L Olesen, T S Jensen
Drug Safety|April 22, 2008
Drug-induced urinary retention: incidence, management and preventionKatia M C Verhamme, Miriam C J M Sturkenboom, Bruno H Ch Stricker, et al.
Pageof 309